Duncan Browman

1.7k total citations
10 papers, 1.3k citations indexed

About

Duncan Browman is a scholar working on Molecular Biology, Physiology and Cell Biology. According to data from OpenAlex, Duncan Browman has authored 10 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 4 papers in Physiology and 3 papers in Cell Biology. Recurrent topics in Duncan Browman's work include Prion Diseases and Protein Misfolding (3 papers), Erythrocyte Function and Pathophysiology (2 papers) and Alzheimer's disease research and treatments (2 papers). Duncan Browman is often cited by papers focused on Prion Diseases and Protein Misfolding (3 papers), Erythrocyte Function and Pathophysiology (2 papers) and Alzheimer's disease research and treatments (2 papers). Duncan Browman collaborates with scholars based in France, Canada and Australia. Duncan Browman's co-authors include Stephen M. Robbins, Laura D. Zajchowski, Chiara Zurzolo, Zrinka Marijanovic, Anna Caputo, Christelle Langevin, Karine Gousset, Jean‐Christophe Olivo‐Marín, Jost Enninga and Angelo Martino and has published in prestigious journals such as Journal of Biological Chemistry, PLoS ONE and Nature Cell Biology.

In The Last Decade

Duncan Browman

10 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Duncan Browman France 8 783 312 211 191 144 10 1.3k
Adriana L. Rojas Spain 19 940 1.2× 644 2.1× 266 1.3× 162 0.8× 85 0.6× 44 1.6k
Samantha L. Eaton United Kingdom 19 1.3k 1.7× 107 0.3× 260 1.2× 290 1.5× 201 1.4× 42 1.7k
Pascal Leblanc France 21 1.0k 1.3× 83 0.3× 208 1.0× 244 1.3× 67 0.5× 46 1.4k
Nobuyuki Ide Japan 22 983 1.3× 475 1.5× 67 0.3× 155 0.8× 401 2.8× 33 1.6k
Oishee Chakrabarti India 22 885 1.1× 325 1.0× 119 0.6× 84 0.4× 70 0.5× 46 1.3k
Anthony Anselmo United States 21 964 1.2× 187 0.6× 181 0.9× 51 0.3× 82 0.6× 26 1.6k
Chris Barton United Kingdom 25 1.2k 1.5× 275 0.9× 152 0.7× 195 1.0× 382 2.7× 40 2.1k
Bjørn Holst Denmark 20 991 1.3× 227 0.7× 229 1.1× 29 0.2× 195 1.4× 67 1.4k
Barbara Oswald United States 10 1.2k 1.6× 559 1.8× 323 1.5× 100 0.5× 172 1.2× 12 1.8k
Hermann C. Altmeppen Germany 23 1.1k 1.4× 158 0.5× 477 2.3× 224 1.2× 128 0.9× 53 1.6k

Countries citing papers authored by Duncan Browman

Since Specialization
Citations

This map shows the geographic impact of Duncan Browman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Duncan Browman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Duncan Browman more than expected).

Fields of papers citing papers by Duncan Browman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Duncan Browman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Duncan Browman. The network helps show where Duncan Browman may publish in the future.

Co-authorship network of co-authors of Duncan Browman

This figure shows the co-authorship network connecting the top 25 collaborators of Duncan Browman. A scholar is included among the top collaborators of Duncan Browman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Duncan Browman. Duncan Browman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Weisser, Nina E., Grant Wickman, Libin Abraham, et al.. (2021). Abstract 1005: The bispecific antibody zanidatamab's (ZW25's) unique mechanisms of action and durable anti-tumor activity in HER2-expressing cancers. Cancer Research. 81(13_Supplement). 1005–1005. 17 indexed citations
2.
Wang, Qiao‐Ping, Duncan Browman, Herbert Herzog, & G. Gregory Neely. (2018). Non-nutritive sweeteners possess a bacteriostatic effect and alter gut microbiota in mice. PLoS ONE. 13(7). e0199080–e0199080. 107 indexed citations
3.
Wang, Qiao‐Ping, Yong Lin, Yana A. Wilson, et al.. (2016). Sucralose Promotes Food Intake through NPY and a Neuronal Fasting Response. Cell Metabolism. 24(1). 75–90. 81 indexed citations
4.
Browman, Duncan & Chiara Zurzolo. (2013). Not on the menu. Prion. 7(4). 286–290. 5 indexed citations
5.
Marijanovic, Zrinka, et al.. (2013). 4-hydroxytamoxifen leads to PrPSc clearance by conveying both PrPC and PrPSc to lysosomes independently of autophagy. Journal of Cell Science. 126(Pt 6). 1345–54. 36 indexed citations
6.
Browman, Duncan, et al.. (2009). Distinct Regions within the Erlins Are Required for Oligomerization and Association with High Molecular Weight Complexes. Journal of Biological Chemistry. 284(12). 7766–7776. 31 indexed citations
7.
Gousset, Karine, Christelle Langevin, Zrinka Marijanovic, et al.. (2009). Prions hijack tunnelling nanotubes for intercellular spread. Nature Cell Biology. 11(3). 328–336. 484 indexed citations
8.
Gousset, Karine, et al.. (2008). Prions hijack tunneling nanotubes for intercellular spread. BMC Proceedings. 2(S1). 2 indexed citations
9.
Browman, Duncan, et al.. (2007). The SPFH domain-containing proteins: more than lipid raft markers. Trends in Cell Biology. 17(8). 394–402. 302 indexed citations
10.
Browman, Duncan, et al.. (2006). Erlin-1 and erlin-2 are novel members of the prohibitin family of proteins that define lipid-raft-like domains of the ER. Journal of Cell Science. 119(15). 3149–3160. 191 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026